Riccardo Tajè

Dr. Riccardo Tajè


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FGFilippo Tommaso Gallina
Filippo Tommaso Gallina
RTRiccardo Tajè
Riccardo Tajè
DFDaniele Forcella
Daniele Forcella
FCFelicita Corzani
Felicita Corzani
VCVirna Cerasoli
Virna Cerasoli
Francesco FaccioloFrancesco Facciolo
Francesco Facciolo
Background: While the thoracotomy approach was considered the gold standard until two decades ago, robotic surgery has increasingly strengthened its role in lung cancer treatment, improving patients’ peri-operative outcomes. In this study, we report our experience in robotic lobectomy for early-stage non-small cell lung cancer, with particular attention to oncological outcomes and nodal upstaging rate. Methods: We retrospectively reviewed patients who underwent lobectomy and radical lymphadenectomy at our Institute between 2016 and 2020. We selected 299 patients who met the inclusion criteria of the study. We analyzed the demographic features of the groups as well as their nodal upstaging rate after pathological examination. Then, we analyzed disease-free and overall survival of the entire enrolled patient population and we compared the same oncological outcomes in the upstaging and the non-upstaging group. Results: A total of 299 patients who underwent robotic lobectomy were enrolled. After surgery, 55 patients reported nodal hilar or mediastinal upstaging. The 3-year overall survival of the entire population was 82.8%. The upstaging group and the non-upstaging group were homogeneous for age, gender, smoking habits, clinical stage, tumor site, tumor histology. The non-upstaging group had better OS (p = 0.004) and DFS (p < 0.0001). Conclusion: Our results show that robotic surgery is a safe and feasible approach for the treatment of early-stage NSCLC, especially for its accuracy in mediastinal lymphadenectomy. The oncological outcomes were encouraging and consistent with previous findings.

17 September 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DADaniela Assisi
Daniela Assisi
FGFilippo Tommaso Gallina
Filippo Tommaso Gallina
DFDaniele Forcella
Daniele Forcella
RTRiccardo Tajè
Riccardo Tajè
EMEnrico Melis
Enrico Melis
Francesco FaccioloFrancesco Facciolo
Francesco Facciolo
Background: Endoscopic ultrasound (EUS) plays an important role in the diagnosis and staging of thoracic disease. Our report studies the diagnostic performance and clinical impact of EUS fine needle aspiration (FNA) in a homogenous cohort of patients according to the distribution of the enlarged MLNs or pulmonary masses. Methods: We retrospectively reviewed the diagnostic performance of 211 EUS-FNA in 200 consecutive patients with enlarged or PET-positive MLNs and para-mediastinal masses who were referred to our oncological center between January 2019 and May 2020. Results: The overall sensitivity of EUS-FNA was 85% with a corresponding negative predictive value (NPV) of 56% and an accuracy of 87.5%. The sensitivity and accuracy in patients with abnormal MLNs were 81.1% and 84.4%, respectively. In those with para-mediastinal masses, sensitivity and accuracy were 96.4% and 96.8%. The accuracy for both masses and lymph nodes was 100%, and in the LAG (left adrenal gland), it was 66.6%. Conclusions: Our results show that, in patients with suspected mediastinal masses, EUS-FNA is an accurate technique to evaluate all reachable mediastinal nodal stations, including station 5.

22 March 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RTRiccardo Tajè
Riccardo Tajè
MPMichael Peer
Michael Peer
FGFilippo Tommaso Gallina
Filippo Tommaso Gallina
VAVincenzo Ambrogi
Vincenzo Ambrogi
ASAzzam Sharbel
Azzam Sharbel
EPEugenio Pompeo
Eugenio Pompeo
Introduction: Robotic and thoracoscopic surgery are being increasingly adopted as minimally invasive alternatives to open sternotomy for complete thymectomy. The superior maneuverability range and three-dimensional magnified vision are potential ergonomical advantages of robotic surgery. To compare the ergonomic characteristics of robotic versus thoracoscopic thymectomy, a previously developed scoring system based on impartial findings was employed. The relationship between ergonomic scores and perioperative endpoints was also analyzed. Methods: Perioperative data of patients undergoing robotic or thoracoscopic complete thymectomy between January 2014 and December 2022 at three institutions were retrospectively retrieved. Surgical procedures were divided into four standardized surgical steps: lower-horns, upper-horns, thymic veins and peri-thymic fat dissection. Three ergonomic domains including maneuverability, exposure and instrumentation were scored as excellent(score-3), satisfactory(score-2) and unsatisfactory(score-1) by three independent reviewers. Propensity score matching (2:1) was performed, including anterior mediastinal tumors only. The primary endpoint was the total maneuverability score. Secondary endpoints included the other ergonomic domain scores, intraoperative adverse events, conversion to sternotomy, operative time, post-operative complications and residual disease. Results: A total of 68 robotic and 34 thoracoscopic thymectomies were included after propensity score matching. The robotic group had a higher total maneuverability score (p = 0.039), particularly in the peri-thymic fat dissection (p = 0.003) and peri-thymic fat exposure score (p = 0.027). Moreover, the robotic group had lower intraoperative adverse events (p = 0.02). No differences were found in residual disease. Conclusions: Robotic thymectomy has shown better ergonomic maneuverability compared to thoracoscopy, leading to fewer intraoperative adverse events and comparable early oncological results.

29 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RTRiccardo Tajè
Riccardo Tajè
RFRoberto Fiorito
Roberto Fiorito
APAlexandro Patirelis
Alexandro Patirelis
VMValentina Marziali
Valentina Marziali
VAVincenzo Ambrogi
Vincenzo Ambrogi
Mesothelioma has a scant prognosis and a great impact on symptoms and the quality of life. Pleurectomy/decortication and extrapleural pneumonectomy are the two cytoreductive surgical strategies, with different invasiveness, but achieving similar oncological results. Hereafter, the two surgical procedures effects on symptoms and the quality of life are compared in a high symptom-burden population. Between 2003 and 2017, 55 consecutive patients underwent pleurectomy/decortication (n = 26) or extrapleural pneumonectomy (n = 29), both followed by adjuvant chemo-radiotherapy. Cardio-pulmonary function, symptoms and the quality of life (Short-Form-36 and St.George’s questionnaires) were evaluated pre- and 3-, 6-, 12- and 24-months postoperatively. Extrapleural pneumonectomy demonstrated lower pain at 12 months but a higher decrement of forced vital capacity at 24 months than pleurectomy/decortication. Both procedures revealed a 3-months improvement of many symptoms and the quality of life determinants. Improvement in physical, social and pain-related measured parameters lasted for a longer time-spawn in the extrapleural pneumonectomy group. No differences were found in chemotherapy compliance and survival between groups. Age-at-presentation (p = 0.02) and non-epitheliod histology (p = 0.10) were the only significant prognosticators. Surgery, despite poor survival results, improved symptoms and the quality of life in patients with mesothelioma with high symptom-burden at diagnosis. Therefore, extrapleural pneumonectomy demonstrated the most durable effects.

16 December 2025 in Cancers
Verified
Journal Article
Open access
PDF file
FGFilippo Tommaso Gallina
Filippo Tommaso Gallina
SLSonia Lucchese
Sonia Lucchese
AVAntonello Vidiri
Antonello Vidiri
FLFrancesca Laganaro
Francesca Laganaro
SRSergio Ruggiero
Sergio Ruggiero
SMSimona Marzi
Simona Marzi
Background:The presence of visceral pleural invasion (VPI) is associated with increased risk of recurrence and reduced overall survival following surgical resection. We aimed to develop machine learning (ML)-based classification models that integrate clinical variables and both tumoral and peritumoral radiomic features to predict VPI in patients with lung adenocarcinoma before surgery. Methods: We retrospectively enrolled 118 patients, including 80 (68%) without VPI and 38 (32%) with histologically confirmed VPI. All patients underwent preoperative contrast-enhanced CT scans. Tumor volumes were manually segmented, and isotropic expansions of 3, 5, and 10 mm were automatically generated to define peritumoral regions. The dataset was randomly split into training (70%) and validation (30%) cohorts. Radiomic features and clinical data were used to train multiple ML algorithms. Results: Pleural Tag Sign and the Worst Histotype were identified as the strongest clinical predictors of VPI. The combined model, integrating radiomics from the lesion and clinical variables, achieved the highest training accuracy of 0.88 (95% CI: 0.80–0.92) and validation accuracy of 0.83 (95% CI: 0.68–0.92). Conclusions: VPI is associated with detectable alterations in both tumoral and peritumoral microenvironment on contrast-enhanced CT. Incorporating radiomic features with clinical data enabled improved model performance compared to clinical-only models, yielding very good accuracies. This approach may support surgical planning and patient risk stratification. Further prospective studies are needed to validate these findings and assess their clinical impact.

31 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
FGFilippo Tommaso Gallina
Filippo Tommaso Gallina
SLSonia Lucchese
Sonia Lucchese
AVAntonello Vidiri
Antonello Vidiri
FLFrancesca Laganaro
Francesca Laganaro
SRSergio Ruggiero
Sergio Ruggiero
SMSimona Marzi
Simona Marzi
Background: The presence of visceral pleural invasion (VPI) is associated with increased risk of recurrence and reduced overall survival following surgical resection. We aimed to develop machine learning (ML)-based classification models that integrate clinical varia-bles and both tumoral and peritumoral radiomic features to predict VPI in patients with lung adenocarcinoma before surgery. Methods: We retrospectively enrolled 118 patients, including 80 (68%) without VPI and 38 (32%) with histologically confirmed VPI. All pa-tients underwent preoperative contrast-enhanced CT scans. Tumor volumes were manu-ally segmented, and isotropic expansions of 3, 5, and 10 mm were automatically generat-ed to define peritumoral regions. The dataset was randomly split into training (70%) and validation (30%) cohorts. Radiomic features and clinical data were used to train multiple ML algorithms. Results: Pleural Tag Sign and the Worst Histotype were identified as the strongest clinical predictors of VPI. The combined model, integrating radiomics from the lesion and clinical variables, achieved the highest training accuracy of 0.88 (95% CI: 0.80–0.92) and validation accuracy of 0.83 (95% CI: 0.68–0.92). Conclusion: VPI is associated with detectable alterations in both tumoral and peritumoral microenvironment on con-trast-enhanced CT. Incorporating radiomic features with clinical data enabled improved model performance compared to clinical-only models, yielding very good accuracies. This approach may support surgical planning and patient risk stratification. Further prospec-tive studies are needed to validate these findings and assess their clinical impact.